A key factor enabling success in the biotechnology industry is the partnership of experienced management, world-class science and visionary financing. ETP uses our extensive network to bring these critical pieces together, providing a solid foundation for the growth of a company.
We invest in companies which :
- Develop drugs to address large unmet clinical needs.
- Develop a proprietary technology platform addressing a rapidly growing market.
- Recruit an experienced management team with proven industry expertise.
- Provide a substantial return on invested capital
ETP typically invests between $500,000 and $3,000,000 in a single round, committing as much as $5,000,000 to a company over a series of financings. We will invest as early as the seed stage and as late as pre-IPO rounds. ETP is comfortable acting as a lead investor or partner in syndicated rounds where the key elements for success are already in place.
ETP is prepared to fund companies that seek to commercialize products within the following areas:
- Antibody and Cell based Therapeutics
- Small Molecule Therapeutics
- Drug Delivery Technologies
- Drug Discovery Technologies
- Drug Targets Discovery and Validation Platforms
- Molecular Diagnostics
- Genomics Tools